Published
2 years agoon
By
NewsIsrael’s Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer’s COVID-19 vaccine, though it has not yet drawn any conclusions.
Pfizer said it has not observed a higher rate of the condition than would normally be expected in the general population.
Israel’s pandemic response coordinator, Nachman Ash, said that a preliminary study showed “tens of incidents” of myocarditis occurring among more than 5 million vaccinated people, primarily after the second dose.
Ash said it was unclear whether this was unusually high and whether it was connected to the vaccine.
“The Health Ministry is currently examining whether there is an excess in morbidity (disease rate) and whether it can be attributed to the vaccines,” Ash said.
By Reuters Staff | 25 April 2021